Dianthus Therapeutics, Inc. logo DNTH - Dianthus Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $111.91 DETAILS
HIGH: $145.00
LOW: $55.00
MEDIAN: $120.00
CONSENSUS: $111.91
UPSIDE: 29.41%

Profitability Ratios

Ratio Value
GP Margin 100.0%
EBIT Margin -8739.3%
EBITDA Margin -8739.3%
Operating Margin -8739.3%
Pretax Margin -7973.3%
Cont. Ops Margin -7973.3%
Net Margin -7973.3%
Bottom Line Margin -7973.3%

Liquidity Ratios

Ratio Value
Current Ratio 13.32
Quick Ratio 13.32
Solvency Ratio -4.327
Cash Ratio 1.66

Valuation Ratios

Ratio Value
Price/Earnings
-9.59
Peers avg: 45.4
PEG Ratio -0.15
Forward PEG -0.15
Price/Book 3.16
Price/Sales 764.98
Price/FCF -12.05
Price/Op Cash Flow -12.07

Debt Ratios

Ratio Value
Debt/Assets 0.0026
Debt/Equity 0.0028
Debt/Capital 0.0028
Long-Term Debt/Capital 0.0021
Financial Leverage 1.08

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.01
Operating Cash Flow Ratio -4.200
Operating Cash Flow/Sales -6338.9%
Free Cash Flow/Operating Cash Flow 100.2%

Coverage Ratios

Ratio Value
Debt Service Coverage -484.83
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -351.66
Operating Cash Flow Coverage -93.12
Capital Expenditure Coverage -605.92
Dividend + Capital Expenditure Coverage -605.92

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.05
EPS -4.295
Debt/Share 0.0367
Cash/Share 10.70
Book Value/Share 13.05
Tangible BV/Share 13.05
Equity/Share 13.05
Operating Cash Flow/Share -3.415
Capital Expenditure/Share 0.006
FCF/Share -3.420

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.912
Price/Fair Value 3.16
Debt/Market Cap 0.0009
Effective Tax Rate 0.0%
Enterprise Value Multiple -8.47